Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-01T04:34:54.377Z Has data issue: false hasContentIssue false
  • English
  • Français

The Direct Costs of Nosocomial Catheter-Associated Urinary Tract Infection in the Era of Managed Care

Published online by Cambridge University Press:  02 January 2015

Paul A. Tambyah ,
Valerie Knasinski  and
Dennis G. Maki
Paul A. Tambyah*
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, University of Wisconsin, Madison, Wisconsin
Valerie Knasinski
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, University of Wisconsin, Madison, Wisconsin
Dennis G. Maki
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, University of Wisconsin, Madison, Wisconsin
*
Department of Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the additional direct costs of hospitalization attributable to catheter-associated urinary tract infection (CAUTI) in 1,497 newly catheterized patients.

Design:

Prospective observational and laboratory study.

Setting:

University hospital.

Methods:

Data were collected on risk factors for CAUTI (defined as > 103 colony-forming units [CFU]/mL), severity of illness, and diagnostic and therapeutic interventions in consenting newly catheterized patients. Daily urine cultures were obtained from each newly catheterized patient, but the results of these cultures were not revealed to his or her physician. During the study, one of the investigators (DGM) reviewed each patient's record and made a judgment as to which of the diagnostic tests and treatments ordered and what incremental length of stay could reasonably be ascribed to his or her CAUTI. The total hospital costs for each patient were also obtained.

Results:

Overall, 235 patients acquired CAUTIs during the study; most of the CAUTIs were completely asymptomatic, and only 52% were diagnosed by the patients' physicians using the hospital laboratory. Only 1 patient with a CAUTI had a secondary bloodstream infection. Thirty-three (13%) of the CAUTIs were caused by Escherichia coli; 63 (25%) by Klebsiella, Enterobacter, Citrobacter, Pseudomonas aeruginosa, or other antibiotic-resistant, gram-negative bacilli; 87 (35%) by enterococci or staphylococci; and 67 (27%) by Candida species. The 123 CAUTIs diagnosed by the hospital laboratory were judged to have been responsible for an additional $20,662 in extra costs of diagnostic tests and $35,872 in extra medication costs, a mean of $589 (median, $356) per CAUTI. CAUTIs caused by E. coli cost considerably less than infections caused by other gram-negative bacilli ($363.3 ± $228.2 vs $690.4 ± $783.7; P = .02) or yeasts ($821.2 ± $2,169.9). There were less striking differences in the costs per CAUTI caused by staphylococci or enterococci ($387.1 ± $434.8).

Conclusions:

The extra direct costs associated with nosocomial CAUTI found in this prospective study, which was done in the era of managed care during the late 1990s, are substantially lower than those reported in the largest comparable studies done more than 15 years ago, most of which were retrospective, reflecting the powerful impact of cost-containment measures that are now implemented in managed care.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 1 , January 2002 , pp. 27 - 31
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kunin, CM. Care of the urinary catheter. In: Kunin, CM, ed. Urinary Tract Infections: Detection, Prevention and Management, 5th ed. Baltimore, MD: Williams & Wilkins; 1997:227–279.Google Scholar
2.Stamm, WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis and prevention. Am J Med 1991;91(suppl 3B):65S–71S.CrossRefGoogle ScholarPubMed
3.Warren, JW. The catheter and urinary tract infection. Med Clin North Am 1991;75:481–493.Google Scholar
4.Siebert, JD, Thomson, RB, Tan, JS, Gerson, LW. Emergence of anti-microbial resistance in gram-negative bacilli causing bacteremia during therapy. Am J Clin Pathol 1993;100:47–51.Google Scholar
5.Jarlier, V, Fosse, T, Philippon, A. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals. Intensive Care Medicine 1996;22:1057–1065.Google Scholar
6.Bjork, DT, Pelletier, LL, Tight, RR. Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients. Infect Control 1984;5:173–176.CrossRefGoogle ScholarPubMed
7.Gaynes, RP, Weinstein, RA, Chamberlin, W, Kabins, S. Antibiotic-resistant flora in nursing home patients admitted to hospital. Arch Intern Med 1985;145:1804–1807.CrossRefGoogle Scholar
8.Kirby, WMM, Corpron, DO, Tanner, DC. Urinary tract infections caused by antibiotic-resistant coliform bacilli. JAMA 1956;162:1.CrossRefGoogle Scholar
9.Lam, S, Singer, C, Tucci, V, Morthland, VH, Pfaller, MA, Isenberg, HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995;23:170–180.Google Scholar
10.Schaberg, DR, Haley, RW, Highsmith, AK, Anderson, RL, McGowan, JE. Nosocomial bacteriuria: a prospective study of case clustering and antimicrobial resistance. Ann Intern Med 1980;93:420–424.Google Scholar
11.Shlaes, DM, Lehman, MH, Currie-McCumber, CA, Kim, CH, Floyd, R. Prevalence of colonization with antibiotic resistant gram-negative bacilli in a nursing home care unit: the importance of cross-colonization as documented by plasmid analysis. Infect Control 1986;7:538–545.CrossRefGoogle Scholar
12.Rice, L, Willey, SH, Papanicolau GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193–2199.Google Scholar
13.Naber, KG, Witte, W, Bauernfeind, A, et al. Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalized urological patients. Infection 1994;22:S122–S127.CrossRefGoogle Scholar
14.Givens, CD, Wenzel, RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol 1980;124:646–648.CrossRefGoogle Scholar
15.Haley, RW, Schaberg, DR, Crossley, KB, von Allmen, SD, McGowan, JE. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981;70:51–58.Google Scholar
16.Coello, R, Glenister, H, Fereres, J, et al. The cost of infection in surgical patients: a case control study. J Hosp Infect 1993;25:239–250.Google Scholar
17.Scheckler, WE. Hospital costs of nosocomial infections: a prospective three month study in a community hospital. Infect Control 1979;1:150–152.Google Scholar
18.Maki, DG, Knasinski, V, Tambyah, PA. A prospective investigator-blinded trial of a novel nitrofurazone-impregnated indwelling urinary catheter. Infect Control Hosp Epidemiol 1997;18(suppl):P50. Abstract.Google Scholar
19.Maki, DG, Knasinski, V, Halvorson, K, Tambyah, PA. A novel silver-hydrogel-impregnated indwelling catheter reduces CAUTIs: a prospective double-blind trial. Presented at the Annual Meeting of the Society for Healthcare Epidemiology of America; April 5-7, 1998; Orlando, FL.Google Scholar
20.Garibaldi, RA, Burke, JP, Dickman, ML, Smith, CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 1974;291:215–219.Google Scholar
21.Platt, R, Polk, BF, Murdock, B, Rosner, B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977–985.CrossRefGoogle ScholarPubMed
22.Johnson, JR. Roberts, PL, Olsen, RJ, Moyer, KA, Stamm, WE. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990;162:1145–1150.Google Scholar
23.Stark, RP, Maki, DG. Bacteriuria in the catheterized patient: what quantitative level of bacteriuria is relevant? N Engl J Med 1984;311:560–564.Google Scholar
24.Balows, LE, Hausler, W, Shadomy, H, eds. Manual of Clinical Microbiology, 3rd ed. Washington, DC: American Society of Microbiology; 1992.Google Scholar
25.Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers (CPI-U) Index Series. Washington, DC: Office of Publications, Bureau of Labor Statistics; 2000.Google Scholar
26.Tambyah, PA, Maki, DG. Catheter-associated urinary tract infection is rarely symptomatic; a prospective study of 1,497 catheterized patients. Arch Intern Med 2000;160:678–682.Google Scholar
27.Jarvis, WR, Martone, WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29:19–24.Google Scholar
28.Bronsema, DA, Adams, JR, Pallares, R, Wenzel, RP. Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. J Urol 1993;150:414–416.Google Scholar
29.Robinson, JC. Decline in hospital utilization and cost inflation under managed care in California. JAMA 1996;276:1060–1064.Google Scholar
30.Drake, DF. Managed care: a product of market dynamics. JAMA 1997;277:560–563.CrossRefGoogle ScholarPubMed
31.Spengler, RF, Greenlough, WB IIIHospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455–2458.Google Scholar
32.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598–1601.Google Scholar
33.Maki, DG, Tambyah, PA. Engineering out the risk of infection with urinary catheters. Emerg Infect Dis 2001;7:342–347.CrossRefGoogle ScholarPubMed
34.Saint, S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000;28:68–75.Google Scholar
35.Saint, S, Veenstra, DL, Sullivan, SD, Chenoweth, C, Fendrick, M. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med 2000;160:2670–2675.Google Scholar